Pediatric anophthalmic sockets and orbital implants: outcomes with polymer-coated implants.

[1]  C. Rodríguez-Galindo,et al.  The effect of cancer therapies on pediatric anophthalmic sockets. , 2011, Ophthalmology.

[2]  H. Lew,et al.  Exposure rate of hydroxyapatite orbital implants a 15-year experience of 802 cases. , 2008, Ophthalmology.

[3]  S. Sandramouli,et al.  Porous Polyethylene (Medpor) Orbital Implants with Primary Acellular Dermis Patch Grafts , 2008, Orbit.

[4]  L. Lin,et al.  Porous orbital implants, wraps, and PEG placement in the pediatric population after enucleation. , 2007, American journal of ophthalmology.

[5]  K. Trinkaus,et al.  Porous Implant Exposure: Incidence, Management, and Morbidity , 2007, Ophthalmic plastic and reconstructive surgery.

[6]  Chin-Shang Li,et al.  Comparison of Orbital Volumes in Enucleated Patients With Unilateral Retinoblastoma: Hydroxyapatite Implants Versus Silicone Implants , 2006, Ophthalmic plastic and reconstructive surgery.

[7]  C. Shields,et al.  Experience with the polymer-coated hydroxyapatite implant after enucleation in 126 patients. , 2007, Ophthalmology.

[8]  P. Custer,et al.  Complications of Sclera-Covered Enucleation Implants , 2006, Ophthalmic plastic and reconstructive surgery.

[9]  S. Gilberg,et al.  Coralline Hydroxyapatite Orbital Implant (Bio-Eye): Experience with 158 Patients , 2004, Ophthalmic plastic and reconstructive surgery.

[10]  S. Kaltreider,et al.  Orbital implants in enucleation surgery: a report by the American Academy of Ophthalmology. , 2003, Ophthalmology.

[11]  S. Gilberg,et al.  The Use of Vicryl Mesh in 200 Porous Orbital Implants: A Technique With Few Exposures , 2003, Ophthalmic plastic and reconstructive surgery.

[12]  M. Duffy,et al.  Exposure Rates of Wrapped and Unwrapped Orbital Implants Following Enucleation , 2001, Ophthalmic plastic and reconstructive surgery.

[13]  S. Kaltreider,et al.  Pediatric enucleation: analysis of volume replacement. , 2001, Archives of ophthalmology.

[14]  N. Davies,et al.  Exposure of primary orbital implants in postenucleation retinoblastoma patients. , 2000, Ophthalmology.

[15]  R. Goldberg,et al.  The Safety and Applications of Acellular Human Dermal Allograft in Ophthalmic Plastic and Reconstructive Surgery: A Preliminary Report , 2000, Ophthalmic plastic and reconstructive surgery.

[16]  J. O'Brien,et al.  Evaluation of efficacy and complications: primary pediatric orbital implants after enucleation. , 2000, Archives of ophthalmology.

[17]  B. Haik,et al.  Wrapping hydroxyapatite orbital implants with posterior auricular muscle complex grafts. , 1999, American journal of ophthalmology.

[18]  R. W. Curran,et al.  Fibrovascular ingrowth in porous ocular implants: the effect of material composition, porosity, growth factors, and coatings. , 1999, Ophthalmic plastic and reconstructive surgery.

[19]  A. Murphree,et al.  Orbital development after enucleation in early childhood. , 1999, Ophthalmic Plastic and Reconstructive Surgery.

[20]  M. Mazow,et al.  Use of the hydroxyapatite ocular implant in the pediatric population. , 1995, Archives of ophthalmology.

[21]  Ashutosh Kumar Singh,et al.  Problems with the hydroxyapatite orbital implant: experience with 250 consecutive cases. , 1994, The British journal of ophthalmology.

[22]  J. Dutton,et al.  Rate of vascularization of coralline hydroxyapatite ocular implants. , 1992, Ophthalmology.

[23]  C. Shields,et al.  Histopathologic evidence of fibrovascular ingrowth four weeks after placement of the hydroxyapatite orbital implant. , 1991, American journal of ophthalmology.